Click to Enlarge
Facebook
Twitter
The Financial Times focuses on the pause of the Johnson and Johnson vaccine rollout in Europe as US agencies review concerns over rare blood clots – similar to those seen in the AstraZeneca jab. The US review is due to be complete in “a matter of days”, the paper says, and Johnson and Johnson took the decision itself to halt the use of its jab in Europe.

Financial Times Front Page 4th of February 2026

Police have opened a criminal inquiry into Lord Mandelson’s dealings with Jeffrey Epstein, examining claims sensitive information was shared while he held government roles. Mandelson has resigned from the Lords. Starmer called the conduct disgraceful and urged full co‑operation.

Read More »

Financial Times Front Page 2nd of February 2026

Emails reveal Peter Mandelson advised Jeffrey Epstein that JPMorgan should pressure the UK over the 2009 bankers’ bonus tax, urging contact with the chancellor. He says he sought to protect jobs and investment. Labour is under pressure to address the revelations.

Read More »

Financial Times Front Page 31st of January 2026

Donald Trump nominated Kevin Warsh to lead the Fed, signalling a firmer stance on inflation. Markets backed the dollar and trimmed expectations of rapid rate cuts. US yields rose while gold fell as investors priced in steadier policy and renewed questions over central bank independence.

Read More »